摘要
美国胸科学会、欧洲呼吸学会、日本呼吸学会和拉丁美洲胸科协会联合修订的2015年版特发性肺纤维化诊断和管理的循证指南中没有强烈推荐治疗的药物，仅提出了一些有条件的情况下推荐使用的药物如吡非尼酮、尼达尼布以及抗酸治疗。因此，对于特发性肺纤维化患者来说，需要特别重视非药物治疗的方法。本文就目前可开展的用于治疗特发性肺纤维化的氧疗、机械通气、肺康复、姑息治疗和肺移植等一些非药物治疗方法作一综述。
In 2015,American Thoracic Society/European Respiratory Society/Japanese Respiratory Society/Latin American Thoracic Association updated the evidence-based guideline on treatment of idiopathic pulmonary fibrosis. There was no highly recommended medical treatment in this evidence-based guideline. Some medications such as pirfenidone, nintedanib, and antacid therapy were lowly recommended. Therefore, non-pharmacological therapy for patients with idiopathic pulmonary fibrosis need to pay attention to. This article reviews the non-pharmacological therapy such as oxygen therapy, mechanical ventilation, pulmonary rehabilitation, palliative care, and lung transplantation on idiopathic pulmonary fibrosis.
作者
程洁
毛燕君
鲁敏
陆海晴
黎金玲
Cheng Jie;Mao Yanjun;Lu Min;Lu Haiqing;Li Jinling(Department of Respiratory Medicine,Shanghai Pulmonary Hospital affiliated to Tongji University,Shanghai 200433,China)
出处
《国际呼吸杂志》
2018年第15期1194-1198,共5页
International Journal of Respiration
关键词
特发性肺纤维化
非药物治疗
研究进展
Idiopathic pulmonary fibrosis
Non-pharmacological therapy
Progress
